National Bank Financial Boosts Extendicare (TSE:EXE) Price Target to C$40.00

Extendicare (TSE:EXE) had its target price increased by National Bank Financial from C$34.00 to C$40.00 in a research note issued on Wednesday,BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. National Bank Financial’s target price suggests a potential upside of 20.26% from the stock’s current price.

A number of other equities analysts have also recently issued reports on the company. TD Securities upgraded Extendicare from a “hold” rating to a “buy” rating and upped their price objective for the stock from C$19.00 to C$32.00 in a report on Monday, April 6th. Canaccord Genuity Group upgraded Extendicare to a “strong-buy” rating in a report on Monday, May 11th. BMO Capital Markets upped their price objective on Extendicare from C$30.00 to C$38.00 in a report on Wednesday, May 13th. Desjardins set a C$34.50 price objective on Extendicare and gave the stock a “buy” rating in a report on Wednesday, April 22nd. Finally, Canadian Imperial Bank of Commerce upped their price objective on Extendicare from C$22.00 to C$32.00 in a report on Thursday, April 2nd. Two investment analysts have rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company’s stock. According to data from MarketBeat, Extendicare has a consensus rating of “Buy” and a consensus target price of C$32.56.

Extendicare Price Performance

TSE EXE traded down C$0.56 during trading on Wednesday, reaching C$33.26. The company’s stock had a trading volume of 159,347 shares, compared to its average volume of 327,838. The stock has a market capitalization of C$3.15 billion, a PE ratio of 24.47 and a beta of 1.27. The company has a debt-to-equity ratio of 82.55, a current ratio of 1.44 and a quick ratio of 0.98. The firm has a fifty day moving average of C$29.48 and a 200 day moving average of C$25.00. Extendicare has a one year low of C$12.12 and a one year high of C$35.62.

Extendicare (TSE:EXE) last announced its earnings results on Thursday, May 7th. The company reported C$0.42 earnings per share for the quarter. The business had revenue of C$465.22 million for the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%. Analysts expect that Extendicare will post 0.6134729 EPS for the current fiscal year.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.